choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Cough Medication

Cough Medication Newsletter
  • Cough Medicine May Protect Against Some of Parkinson's Worst Symptoms 08 Jul 2025 03:15 GMT

    … in cough medicines since 1979 has shown promise as a treatment for … gold-standard phase 2 clinical trial, 22 participants with Parkinson… Canada. "This early trial offers hope and provides a … GCase activity. In the current trial, those taking the drug …

  • FDA Approves Sunvozertinib in Non–Small Cell Lung Cancer 07 Jul 2025 22:10 GMT

    … report chest pain, chronic cough, loss of appetite, shortness … symptoms. Sunvozertinib is a treatment that has molecular structure … oral reception.1 The medication is an irreversible EGFR … receives-fda-accelerated-approval-as-the-only-targeted-oral-treatment- …

  • Cough syrup protects the brain from dementia in clinical trial first 07 Jul 2025 11:59 GMT

    … 12-month clinical trial investigating the cough medicine Ambroxol and … offers a promising new treatment avenue where few currently … will go on to develop disease-related dementia within … investigating Ambroxol for the treatment of motor neurone disease …

  • Parkinson's: Cough medicine may help slow down cognitive decline 07 Jul 2025 20:18 GMT

    Parkinson’s disease dementia develops in people who have a Parkinson’s disease diagnosis. Experts are interested in finding the best ways to address and prevent Parkinson’s disease dementia. A randomized clinical trial found that the drug Ambroxol may help …

  • Common Cough Medicine Could Slow Parkinson’s-Related Dementia 07 Jul 2025 16:11 GMT

    … investigating whether Ambroxol - a cough medicine used safely for decades … Neurology, this 12-month clinical trial involving 55 participants with Parkinson … is an important step toward developing new treatments for Parkinson’s disease …

  • Q&A: AI-established drug ‘breakthrough in the treatment of IPF’ 07 Jul 2025 15:01 GMT

    … baseline and week 12 Leicester Cough Questionnaire scores, researchers further observed … patents, publications, grants and clinical trial databases to further assess the … it so challenging to develop innovative drugs and treatments for IPF? The main …

  • Cough Medicine Turned Brain Protector? Ambroxol May Slow Parkinson’s Dementia 06 Jul 2025 13:51 GMT

    … with no safe, affordable treatments to slow its progression. … whether Ambroxol -- a cough medicine used safely for … this 12-month clinical trial involving 55 participants with Parkinson … an important step toward developing new treatments for Parkinson's …

  • Bridging Tradition and Science: Ghanaian Home Remedies for C... 05 Jul 2025 11:59 GMT

    remedies. Anecdotally, I have found that my hacking cough … Of note, while steam treatment helps to relieve congestion … when you start to develop symptoms the antiviral effects … research, including controlled clinical trials and standardized protocols, to …

  • Evaluating COPD Risk Through Breath and Cough 05 Jul 2025 09:06 GMT

    In a groundbreaking development poised to transform respiratory healthcare, … smartphones to record exhalation and cough sounds, subsequently analyzing these … progression, predict exacerbations, or evaluate treatment efficacy. With continuous advancements in …

  • Lynozyfic (linvoseltamab-gcpt) Granted FDA Accelerated Approval for Relapsed/Refractory Multiple Myeloma 03 Jul 2025 18:35 GMT

    … in the LINKER-MM1 trial. Continued approval for this … could help reduce treatment burden.” The FDA approval is based … advancing our broad clinical development program for Lynozyfic – … prescribed Lynozyfic access their medication. The company has launched …

Satisfied with the content?

Continue to create your account.